NasdaqCM - Nasdaq Real Time Price USD
Elutia Inc. (ELUT)
1.9000
+0.0800
+(4.40%)
At close: May 13 at 4:00:02 PM EDT
1.8099
-0.09
(-4.74%)
After hours: May 13 at 6:10:11 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.37M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MILLS CHARLES RANDAL Chief Executive Officer | -- | Direct | -- | Mar 10, 2025 |
| FERGUSON MATTHEW B Chief Financial Officer | -- | Direct | -- | Mar 10, 2025 |
| WILLIAMS MICHELLE LEROUX Officer | -- | Direct | -- | Mar 10, 2025 |
| HIGHCAPE CAPITAL, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.50 per share. | Indirect | 1,050,000 | Feb 3, 2025 |
| MILLS CHARLES RANDAL Chief Executive Officer | -- | Direct | -- | Dec 10, 2024 |
| FERGUSON MATTHEW B Chief Financial Officer | -- | Direct | -- | Dec 10, 2024 |
| WILLIAMS MICHELLE LEROUX Officer | -- | Direct | -- | Dec 10, 2024 |
| MILLS CHARLES RANDAL Chief Executive Officer | -- | Direct | -- | Sep 10, 2024 |
| FERGUSON MATTHEW B Chief Financial Officer | -- | Direct | -- | Sep 10, 2024 |
| WILLIAMS MICHELLE LEROUX Officer | -- | Direct | -- | Sep 10, 2024 |
| MILLS CHARLES RANDAL Chief Executive Officer | -- | Direct | -- | Aug 12, 2024 |
| FERGUSON MATTHEW B Chief Financial Officer | -- | Direct | -- | Aug 12, 2024 |
| WILLIAMS MICHELLE LEROUX Officer | -- | Direct | -- | Aug 12, 2024 |
| FERGUSON MATTHEW B Chief Financial Officer | Conversion of Exercise of derivative security at price 1.43 per share. | Direct | 150,002 | Jul 31, 2024 |
| HIGHCAPE CAPITAL, L.P. Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 1.43 per share. | Indirect | 3,000,001 | Jul 30, 2024 |
| MILLS CHARLES RANDAL Chief Executive Officer | -- | Direct | -- | Jun 21, 2024 |
| MILLS CHARLES RANDAL Chief Executive Officer | -- | Direct | -- | Jun 10, 2024 |
| FERGUSON MATTHEW B Chief Financial Officer | -- | Direct | -- | Jun 10, 2024 |
| WILLIAMS MICHELLE LEROUX Officer | -- | Direct | -- | Jun 10, 2024 |
| FERGUSON MATTHEW B Chief Financial Officer | -- | Direct | -- | Mar 8, 2024 |
| FERGUSON MATTHEW B Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 21, 2023 |
| MILLS CHARLES RANDAL Chief Executive Officer | -- | Direct | -- | Jun 21, 2023 |
Related Tickers
TMCI Treace Medical Concepts, Inc.
6.98
-2.99%
SSKN STRATA Skin Sciences, Inc.
2.5500
0.00%
ESTA Establishment Labs Holdings Inc.
34.96
+1.10%
BWAY BrainsWay Ltd.
9.81
+11.10%
XTNT Xtant Medical Holdings, Inc.
0.5966
+14.73%
SONX Sonendo, Inc.
1.2000
-13.04%
TELA TELA Bio, Inc.
0.9800
-2.97%
VREX Varex Imaging Corporation
7.50
-0.27%
NPCE NeuroPace, Inc.
12.95
-3.14%
SGHT Sight Sciences, Inc.
3.4200
+6.54%